The Use of Probiotics for Pain Reduction in Patients With Fibromyalgia: A Systematic Review
Abstract
Background: Probiotics represent a potential therapeutic option for patients with fibromyalgia. Emerging evidence suggests that the gut-brain axis can modulate neuronal-mediated pain symptoms. This systematic review evaluates the efficacy of probiotic supplementation for pain reduction in patients with fibromyalgia.
Methods: Following the PRISMA 2020 guidelines, the databases search included MEDLINE (PubMed), Embase, Scopus, Web of Science, Cochrane CENTRAL, and ClinicalTrials.gov up to April 2025. Eligible studies included randomized controlled trials evaluating the use of probiotics for pain management in adults (age ≥18 years) with fibromyalgia. Interventions were multistrain probiotics for 8–12 weeks; outcomes included VAS pain, FIQ/FIQR, and SF-36. Studies involving pediatric populations, other chronic pain conditions, or lacking pain outcomes were excluded. Risk of bias was assessed using the Cochrane Risk-of-Bias 2 tool. (OSF Registries: https://doi.org/10.17605/OSF.IO/KHVR7)
Results: Of 923 records, 3 double-blind, placebo-controlled RCTs (2018–2024; n=213; 198 women; ages ~46–55; Spain/Turkey) met eligibility criteria and were included. Pain was assessed as a primary and secondary outcome. One trial showed a greater VAS pain reduction with probiotics at 8 weeks (per-protocol; p=0.032; moderate effect), while the other two reported no between-group differences in pain; SF-36 improvements favoring probiotics/prebiotics appeared in one study only. Heterogeneity in…
How strong is the evidence?
Evidence Hub reads this as a systematic review, done in people. Its evidence level is 1 of 5 (Highest · pooled evidence). Pooled evidence from several studies sits at the top of the evidence pyramid. Reported size: 213 participants or records.
Read the paper
Related studies
- In silico strategies for modeling RNA aptamers and predicting binding sites of their molecular targets
- Folic acid-hydrophilic polymer coated mesoporous silica nanoparticles target doxorubicin delivery
- Anti-phytopathogenic and plant growth promoting potential of endophytic fungi isolated from Dysoxylum gotadhora
- Mercury toxicity causes iron and sulfur deficiencies along with oxidative injuries in alfalfa (Medicago sativa)
- Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo
- Assessing the Protective Effect of Moringa oleifera Extract against Bone Metastasis: An In Vitro Simulated Digestion Approach
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.